Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Meta-analysis finds no link between PPI use and risk of dementia

Publish date:: June 3, 2019

Key clinical point: A meta-analysis of evidence suggests no association between a diagnosis of dementia and PPI use.

Major finding: The incidence of dementia was not significantly increased among patients in the PPI-exposed group (OR, 1.08 (95% CI, 0.97-1.20; P = .18).

Study details: A meta-analysis of five studies comprising 472,933 patients.

Disclosures: The researchers reported having no financial disclosures.

Citation:

REPORTING FROM DDW 2019

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

IBD patients prefer vedolizumab over anti-TNF drugs,

During pandemic, many gastroenterologists report low resilience, insomnia,